SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-20-139240
Filing Date
2020-12-23
Accepted
2020-12-23 17:22:27
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A tm2039131d2_s3a.htm S-3/A 230366
2 EXHIBIT 23.1 tm2039131d2_ex23-1.htm EX-23.1 3822
3 GRAPHIC tm2039131d2_s3img001.jpg GRAPHIC 10420
4 GRAPHIC tm2039131d2_ex23-1img001.jpg GRAPHIC 18705
5 GRAPHIC tm2039131d2_ex23-1img002.jpg GRAPHIC 7448
  Complete submission text file 0001104659-20-139240.txt   286036
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: S-3/A | Act: 33 | File No.: 333-250967 | Film No.: 201413588
SIC: 2834 Pharmaceutical Preparations